Replies to post #79711 on Biotech Values

[DewDiligence]

CHMP approves AGN’s Ozurdex biodegradable implant for macular edema:

http://www.reuters.com/article/idCNLDE64K0W820100521

Ozurdex was approved by the FDA for macular edema in Jun 2009 (#msg-38873404); AGN submitted an application for approval in posterior uveitis during 4Q09 (#msg-46265367).